ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,825
-0,03%
Bitcoin
62 871,16
3,25%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Elutia Inc (ELUT)

  7. Elutia Inc (ELUT) Actualités

ELUT

Elutia (ELUT)

Elutia Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ELUT
DateHeureSourceTitreSymboleSociété
18/06/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
17/06/202414h30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELUTElutia Inc
17/06/202414h01GlobeNewswire Inc.Elutia Announces $13.26 Million Registered Direct OfferingNASDAQ:ELUTElutia Inc
17/06/202414h00GlobeNewswire Inc.Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and DefibrillatorsNASDAQ:ELUTElutia Inc
10/06/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
13/05/202423h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
13/05/202414h00GlobeNewswire Inc.Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024NASDAQ:ELUTElutia Inc
09/05/202422h05GlobeNewswire Inc.Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA ClearanceNASDAQ:ELUTElutia Inc
02/05/202422h05GlobeNewswire Inc.Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:ELUTElutia Inc
24/04/202422h05GlobeNewswire Inc.Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1NASDAQ:ELUTElutia Inc
11/03/202414h15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ELUTElutia Inc
07/03/202422h05GlobeNewswire Inc.Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024NASDAQ:ELUTElutia Inc
22/02/202422h05GlobeNewswire Inc.Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024NASDAQ:ELUTElutia Inc
14/02/202422h40Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ELUTElutia Inc
25/01/202422h56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ELUTElutia Inc
10/01/202422h05GlobeNewswire Inc.Elutia Regains Compliance with Nasdaq Listing RequirementsNASDAQ:ELUTElutia Inc
09/01/202422h17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ELUTElutia Inc
18/12/202314h00GlobeNewswire Inc.Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA ClearanceNASDAQ:ELUTElutia Inc
05/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ELUTElutia Inc
20/11/202322h53Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ELUTElutia Inc
13/11/202322h05GlobeNewswire Inc.Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial ResultsNASDAQ:ELUTElutia Inc
09/11/202314h30GlobeNewswire Inc.Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 MillionNASDAQ:ELUTElutia Inc
06/11/202322h05GlobeNewswire Inc.Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023NASDAQ:ELUTElutia Inc
18/10/202314h00PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:ELUTElutia Inc
05/10/202316h24Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
03/10/202317h05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ELUTElutia Inc
20/09/202314h30GlobeNewswire Inc.Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare ConferenceNASDAQ:ELUTElutia Inc
19/09/202314h36GlobeNewswire Inc.Elutia Announces Private Placement for Proceeds Up to $26 MillionNASDAQ:ELUTElutia Inc
18/09/202322h08GlobeNewswire Inc.Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 MillionNASDAQ:ELUTElutia Inc
08/09/202314h30GlobeNewswire Inc.Elutia to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ELUTElutia Inc
 Showing the most relevant articles for your search:NASDAQ:ELUT

Dernières Valeurs Consultées

USI
USTECH100
US Tech 100
EU
CAP
Capgemini
EU
BEL20
Bel 20
EU
ORA
Orange
EU
AI
Air Liquide
NASDAQ
AMZN
Amazon.com
NYSE
DIS
Walt Disney
EU
BN
Danone
EU
DG
Vinci
EU
RNO
Renault
EU
PX4
SBF 120
FTSE
UKX
FTSE 100
EU
VIV
Vivendi
EU
PX1
CAC 40
EU
VK
Vallourec
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés